IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
This study is ongoing, but not recruiting participants.
Sponsor:
OBI Pharma, Inc
Information provided by (Responsible Party):
OBI Pharma, Inc
ClinicalTrials.gov Identifier:
NCT01516307
First received: January 19, 2012
Last updated: March 2, 2017
Last verified: March 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2019 |
| Primary Completion Date: | August 2016 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | March 2, 2017 |